Alexander Cumbo
Director; Director, President and CEO · 7 filings · Latest: Sep 23, 2026
Climb Bio, Inc.
Solid Biosciences Inc.
Stoke Therapeutics, Inc.
Vor Biopharma Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SLDB | Alexander Cumbo | Director, President and CEO | Feb 18, 2026 | Sale | $5.82 | 16,644 | $96.9K | 235,405 | |
SLDB | Alexander Cumbo | Director, President and CEO | Feb 13, 2026 | Option Exercise | — | 30,031 | — | 252,049 | |
SLDB | Cumbo Alexander | — | Feb 18, 2026 | Proposed Sale | $5.82 | 16,644 | $96.9K | — | |
SLDB | Alexander Cumbo | Director, President and CEO | Feb 4, 2026 | Sale | $6.44 | 48,913 | $315.1K | 222,018 | |
SLDB | Cumbo Alexander | — | Feb 4, 2026 | Proposed Sale | $6.44 | 48,913 | $315.1K | — | |
SLDB | Alexander Cumbo | Director, President and CEO | Feb 2, 2026 | Sale | $6.44 | 80,258 | $516.6K | 270,931 | |
SLDB | Alexander Cumbo | Director, President and CEO | Jan 31, 2026 | Option Exercise | — | 100,400 | — | 351,189 | |
SLDB | Alexander Cumbo | Director, President and CEO | Jan 29, 2026 | Option Exercise | — | 169,401 | — | 250,789 | |
SLDB | Cumbo Alexander | — | Feb 2, 2026 | Proposed Sale | $6.44 | 80,258 | $516.6K | — | |
SLDB | Cumbo Alexander | — | Dec 3, 2025 | Proposed Sale | $5.11 | 10,808 | $55.2K | — | |
SLDB | Cumbo Alexander | — | Feb 14, 2025 | Proposed Sale | $3.96 | 11,365 | $45.0K | — | |
SLDB | Cumbo Alexander | — | Dec 3, 2024 | Proposed Sale | $5.60 | 11,114 | $62.2K | — | Dec 5 9:05 PM 144/A |
SLDB | Cumbo Alexander | — | Dec 3, 2024 | Proposed Sale | $5.79 | 10,687 | $61.9K | — |